Rabavert rabies vacc w-diluents
Ended Awarded
- Contract number
- SPE2DB25FRJJ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,079
Award facts
- Contract value 100% obligated
- $54,078.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,078.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of May 5, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single procurement action under AmerisourceBergen's broader federal contract portfolio, which demonstrates the company's critical role as a pharmaceutical distributor supporting federal medical procurement needs.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceuticals, vaccines, and medical supplies to military healthcare systems worldwide. Rabavert rabies vaccine procurement through this mechanism supports the Defense Health Agency and other government healthcare systems' immunization requirements, reflecting the DLA's continued reliance on AmerisourceBergen as a primary vendor for essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FRJJ4?
SPE2DB25FRJJ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FRJJ4 worth?
The government has obligated $54,079 on SPE2DB25FRJJ4.
Is contract SPE2DB25FRJJ4 an order under another contract?
Yes. SPE2DB25FRJJ4 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRJJ4 competed?
The extent of competition for SPE2DB25FRJJ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award